Cytosorbents Corporation is a biotechnology company that specializes in advanced blood purification technologies designed to treat life-threatening conditions in intensive care units and other hospital settings. The company's flagship product, CytoSorb, is a hemoadsorption cartridge that removes cytokines and other inflammatory mediators from blood. This device aims to help control excessive inflammation, which is a critical factor in numerous conditions such as sepsis, cardiac surgery, and trauma. Cytosorbents operates predominantly within the healthcare and medical technology sectors, with its technologies gaining attention for their potential impact on critical care and immunotherapy. Given its focus on innovative medical solutions, the company plays a pivotal role in advancing treatment protocols and improving patient outcomes. Headquartered in Princeton, New Jersey, Cytosorbents continues to expand its reach globally, participating in various clinical trials and partnerships to enhance the adoption and efficacy of its products in modern medical practice.